InvestorsHub Logo
Followers 2
Posts 119
Boards Moderated 0
Alias Born 09/20/2017

Re: m0n post# 209

Sunday, 06/16/2019 3:14:42 PM

Sunday, June 16, 2019 3:14:42 PM

Post# of 289
Savara is presenting at the JP Morgan conference on this coming Wednesday. I think it will be important to listen to what they have to say further about the P3 as they have now had a week to think about it. I am particularly interested in their thoughts about the "unusually" high placebo effect. How can a placebo effect be unusually high? What might be the explanation for that? What might it mean about possible paths forward for a drug that seems to have worked?
Was this group an unusually optimistic group? Are the psychological impacts on lung conditions greater than the psychological impact on other bodily functions? I have no clue, but if there is an answer it could be very important to the future of the drug.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SVRA News